Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 Jun 15

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 Jun 15

DOI: 10.23736/S1824-4785.20.03225-2

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expression

Pierre-Benoît BONNEFOY 1, 2 , Elodie JACQUEROUX 1, Xavier DELAVENNE 1, Frederic ROCHE 3, Anthony CLOTAGATIDE 4, Patrick MISMETTI 1, Nathalie PREVOT 1, 2, Nathalie PEREK 1

1 INSERM U1059 Dysfonction Vasculaire et Hémostase, Université de Lyon, UJM-Saint-Etienne, Saint-Étienne, France; 2 Service de Médecine nucléaire, CHU de Saint-Etienne, Saint-Étienne, France; 3 EA4607 SNA-EPIS, Université de Lyon - UJM-Saint-Etienne, Saint-Etienne, France; 4 Service de Radiopharmacie Clinique, CHU de Saint-Etienne, Saint-Étienne, France



BACKGROUND: Vascular calcification is an established feature of atherosclerosis process. The sodium/phosphate transporter PiT-1 acts as a biosensor in vascular calcification of VSMCs. [99mTc]-Pentavalent dimercaptosuccinic acid (99mTc-(V)-DMSA) was mediated by PiT-1 transporter in tumoral cells and we propose its evaluation in a vascular calcification in vitro model. The aim of this study was to determine if 99mTc-(V)-DMSA can follow the vascular calcification process in vascular smooth muscle cells (VSMCs) based on PiT-1 expression.
METHODS: From a rat aortic VSMC cell line (A7r5), we set up a model of calcification within 7 days using a calcifying medium containing a high inorganic phosphate concentration. Phosphocalcic deposits were monitored with Alizarin red and Von Kossa staining and with phase contrast microscopy. PiT-1 expression was evaluated with an immunofluorescence assay and osteopontin expression, with whole cell ELISA assay. 99mTc-(V)-DMSA uptake was measured in control and calcifying conditions and compared with optical microscopy evaluation.
RESULTS: Under hyperphosphatemia conditions, the VSMC cells progressively overexpressed osteopontin protein, PiT-1 transporter, and synthetized mineralized matrix with phosphocalcic deposition. 99mTc-(V)-DMSA uptake was to 2.8+/-2.08%DA/mg-protein in control cells and 42+/-24%DA/mg-protein in calcified cells (p<0,001). PiT-1 inhibition with phosphonoformic acid completely reverse the calcium deposition as well as the 99mTc-(V)- DMSA uptake. These results demonstrated that 99mTc-(V)-DMSA in vitro uptake is mediated by PiT-1 transporter and follow the VSMC calcification process.
CONCLUSIONS: These preliminary in vitro results showed 99mTc-(V)-DMSA uptake follow the phospho-calcic deposition mediated by PiT-1 transporter. This radiotracer may have some potential to detect changes of VSMC metabolism occurring in the atherosclerosis process.


KEY WORDS: Vascular calcification; 99mTc-(V)-DMSA; PiT-1 transporter; A7r5 cell line; Molecular Imaging

top of page